Bingogroup.com.hk

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. BINGO GROUP HOLDINGS LIMITED
(Formerly known as Emcom International Limited)
(Incorporated in the Cayman Islands with limited liability) FREE EXCHANGE OF SHARE CERTIFICATES
In light of the Change of Name, the Company is pleased to announce that new share certificates of the Company in red will be issued in the new name of the Company in any subsequent issue of Shares. Shareholders may exchange the existing share certificates in blue for new share certificates in red at the branch registrar of the Company in Hong Kong free of charge for one month from 8 September 200 to 7 October 200 (both dates inclusive).
Reference is made to the announcements of the Company dated 4 June 200, and 3 September 200
respectively and the circular (the “Circular”) of the Company dated 30 June 200. Capitalised terms
used herein shall have the same meanings as those defined in the Circular unless defined otherwise.
In light of the Change of Name, the Company is pleased to announce that new share certificates of the Company in red will be issued in the new name of the Company in any subsequent issue of Shares. Shareholders may exchange the existing share certificates in blue for new share certificates in red at the branch registrar of the Company in Hong Kong, Tricor Tengis Limited at 26th Floor, Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong Kong free of charge for one month from 8 September 200 to 7 October 200 (both dates inclusive). Thereafter, any exchange of new share certificates in red will be handled by Tricor Tengis Limited on payment of a fee of HK$2.50 (or such higher fee as may be allowed by the Stock Exchange from time to time) for each share certificate for Shares cancelled or each new share certificate issued, whichever number of certificates cancelled/issued is higher.
All existing share certificates in blue in issue bearing the former name of the Company will continue to be effective as documents of title to the Shares and be valid for trading, settlement and registration purposes.
Bingo Group Holdings Limited
(formerly known as “Emcom International Limited”)
Chan Cheong Yee
As at the date of this announcement, the Company’s executive Directors are Mr. Chiau Sing Chi, Mr. Chan Cheong Yee, and Mr. Yik Chok Man, the Company’s non-executive Directors are Mr. Chong Lee Chang and Mrs. Chin Chow Chung Hang, Roberta, and the Company’s independent non-executive Directors are Mr. Leung Ka Kui, Johnny, Mrs. Chen Chou Mei Mei, Vivien, Mr. Chum Kwan Yue, Desmond and Mr. Wong Chak Keung. This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this document misleading. This announcement will remain on the ‘Latest Company Announcements’ page of the GEM website (www.hkgem.com) for at least 7 days from its date of publication and on the website of the Company at www.bingogroup.com.hk.

Source: http://www.bingogroup.com.hk/files/announcements/1283997202_E_08092010.pdf

Synthroid® (levothyroxine sodium tablets, usp)

PRECAUTIONS General Levothyroxine has a narrow therapeutic index. Regardless of the indication for use, careful dosage titration is necessary to avoid the SYNTHROID® consequences of over- or under-treatment. These consequences include, among others, effects on growth and development, cardiovascularfunction, bone metabolism, reproductive function, cognitive function, emotional state, gastroi

archive.irh.org

Executive summary This document is one important step in a process for improving access to quality of care in family planning by reviewing the medical eligibility criteria for selecting methods of contraception. It updates the second edition of Improving access to quality care in family planning: medical eligibility criteria for contraceptive use, published in 2000, and summarizes the ma

Copyright © 2012-2014 Medical Theses